IP Library Granted Patent US 8,252,161
Granted Patent B2
US 8,252,161 · App. 11/817,461 · Granted Aug 28, 2012

Electrofiltration method

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,252,161
App. No.
11/817,461
Granted
Aug 28, 2012
Kind
B2
Abstract

Method for improving selectivity and productivity during purification of charged macromolecules and particles by electrofiltration by means of membranes in the electric filed. The ratio between the electric field and the permeate flow through the membrane is kept constant.

Claims (9)

1. A method for improving the selectivity and productivity in the purification of a substance comprising charged macromolecules and particles in an electrolyte solution of said substance by electrofiltration from feed media wherein the conductivity of said media changes during said purification by means of a separation membrane in an electric field, wherein the ratio of the strength of the abovementioned electric field to the permeate flow rate through the separation membrane is kept constant and the field strength on the feed side of the membrane in the feed channel is changed in inverse proportion to the changes in the conductivity of the feed medium.

2. The method as claimed in claim 1 , wherein the electric field strength is from 500 to 5000 V/m.

3. The method as claimed in claim 1 , wherein the permeate flow rate between concentrate chamber and permeate chamber is adjusted to keep said ratio of the strength of said electrical field to the permeate flow rate through the separation membrane constant.

4. The method as claimed in claim 1 , wherein the substance being purified is one or more members of the group consisting of proteins, peptides, DNA, RNA, oligonucleotides, oligo- and polysaccharides, viruses, virus constituents, cells, cell constituents, enantiomers and diastereomers.

5. The method as claimed in claim 4 , wherein said substance is proteins, said proteins being monoclonal or polyclonal antibodies.

6. The method as claimed in claim 1 , wherein the membranes have a pore size of from 1 to 1000 nm.

7. The method as claimed in claim 1 , wherein the conductivity of said electrolyte solution is from 20 to 0.5 mS/cm.

8. The method as claimed in claim 1 , wherein the electrolytes in said electrolyte solution are a combination of weak acids and weak bases, weak acids and strong bases or strong acids and weak bases.

9. The method as claimed in claim 1 , wherein the electrolyte solution contains one or more substances selected from the group consisting of boric acid, phosphoric acid, N-2-(acetamido)-2-aminoethanesulfonic acid, N-2-(acetamido)iminodiacetic acid, alanine, 2-amino-2-methyl-1,3-propanediol, ammonia, N,N-bis(2-hydroxyethyl)-2-aminoethanesulfonic acid, N,N-bis(2-hydroxyethyl)glycine, 2,2-bis(hydroxyethyl)iminotris (hydroxymethyl)-methane, 2-(cyclohexylamino)ethanesulfonic acid, acetic acid, glycine, glycylglycine, 2-[4-(2-hydroxyethyl)1-piperazinyl]ethanesulfonic acid, 3-[4-(2-hydroxyethyl)1-piperazinyl]propanesulfonic acid, histidine, imidazole, lactic acid, 2-morpholinoethanesulfonic acid, 2-morpholinopropanesulfonic acid, piperazine-1,4-bis(2-ethanesulfonic acid), N[tris(hydroxymethyl)methyl]-2-aminoethanesulfonic acid, N-[tris(hydroxymethyl)methyl]glycine, triethanolamine, tris(hydroxymethyl)aminomethane and citric acid.

Assignments (2)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Sep 5, 2013
From: BAYER TECHNOLOGY SERVICES GMBH
To: BAYER INTELLECTUAL PROPERTY GMBH
Reel/Frame 031157/0347 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Nov 14, 2007
From: DUDZIAK, GREGOR; TRAVING, MICHAEL; MUTTER, MARTINA
To: BAYER TECHNOLOGY SERVICES GMBH
Reel/Frame 020111/0445 →